Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Smith

Showing results (111-120 of 303) with videos related to

Pageof 31
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 2020
Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful BenefitsDaniel R Richardson, Norah L Crossnohere, Jaein Seo, et al.
Vaccine|April 5, 2020
A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virusSu He Wang, Jesse Chen, Douglas Smith, et al.
The Journal of Rheumatology|July 5, 2005
Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosisJanet E Pope, Peter Lee, Murray Baron, et al.
Cancer Research|July 5, 2005
The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivoRebecca C Osthus, Baktiar Karim, Julia E Prescott, et al.
Leukemia Research|July 12, 2014
Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)Joshua F Zeidner, Douglas E Gladstone, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantationJavier Bolaños-Meade, B Douglas Smith, Steven D Gore, et al.
Current Medical Research and Opinion|June 13, 2019
Side effects from acute myeloid leukemia treatment: results from a national surveyNorah L Crossnohere, Daniel R Richardson, Crystal Reinhart, et al.
The Journal of Community and Supportive Oncology|March 27, 2015
Practice gaps and barriers to optimal care of hematologic malignancies in the United StatesSuzanne Murray, Kevin L Obholz, Andrew D Bowser, et al.
Expert Review of Hematology|November 17, 2015
Economic burden associated with acute myeloid leukemia treatmentAmer M Zeidan, Dalia Mahmoud, Izabela T Kucmin-Bemelmans, et al.
Clinical Transplantation|April 23, 2002
Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibodyThomas A Gonwa, Martin L Mai, Larry B Melton Douglas Smith, et al.
Pageof 31

Showing results (111-120 of 303) with videos related to

Sort By:
Pageof 31
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 2020
Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful BenefitsDaniel R Richardson, Norah L Crossnohere, Jaein Seo, et al.
Vaccine|April 5, 2020
A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virusSu He Wang, Jesse Chen, Douglas Smith, et al.
The Journal of Rheumatology|July 5, 2005
Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosisJanet E Pope, Peter Lee, Murray Baron, et al.
Cancer Research|July 5, 2005
The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivoRebecca C Osthus, Baktiar Karim, Julia E Prescott, et al.
Leukemia Research|July 12, 2014
Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)Joshua F Zeidner, Douglas E Gladstone, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantationJavier Bolaños-Meade, B Douglas Smith, Steven D Gore, et al.
Current Medical Research and Opinion|June 13, 2019
Side effects from acute myeloid leukemia treatment: results from a national surveyNorah L Crossnohere, Daniel R Richardson, Crystal Reinhart, et al.
The Journal of Community and Supportive Oncology|March 27, 2015
Practice gaps and barriers to optimal care of hematologic malignancies in the United StatesSuzanne Murray, Kevin L Obholz, Andrew D Bowser, et al.
Expert Review of Hematology|November 17, 2015
Economic burden associated with acute myeloid leukemia treatmentAmer M Zeidan, Dalia Mahmoud, Izabela T Kucmin-Bemelmans, et al.
Clinical Transplantation|April 23, 2002
Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibodyThomas A Gonwa, Martin L Mai, Larry B Melton Douglas Smith, et al.
Pageof 31